Search
Search Results
##search.searchResults.foundPlural##
-
COMPARISON OF IL-34, ELASTOGRAPHY, AND BIOPSY IN THE ASSESSMENT OF LIVER FIBROSIS IN CHRONIC HEPATITIS B Evaluating Non-Invasive and Invasive Methods in Liver Fibrosis
543PDF: 291Html: 25 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2416PDF: 929HTML: 553 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
819PDF: 540HTML: 4019 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2133PDF: 1697HTML: 378 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2830PDF: 951HTML: 7334 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4508PDF: 1926HTML: 17794 -
CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab
1321PDF: 1133HTML: 119 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2004PDF: 1139HTML: 627 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3282PDF: 1102HTML: 439 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3614PDF: 1109HTML: 23338 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2298PDF: 1327HTML: 17081Bassan Fig.1: 143Bassan Fig.2: 155Bassan Fig.4: 142Fig.3: 187 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
2279PDF: 999HTML: 148Suppl. Files: 512 -
EXTREMELY OLD PATIENTS HOSPITALIZED IN INTERNAL MEDICINE: WHAT ABOUT THEIR ANEMIA? Anemia in the elderly
1577PDF: 505HTML: 234 -
-
A 9month-old-boy with atypical hemophagocytic lymphohistiocytosis
2020PDF: 802HTML: 1037 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1287PDF: 725HTML: 322 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
1710PDF: 1100HTML: 10697Untitled: 189 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2669PDF: 1083HTML: 119 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2455PDF: 1303HTML: 1751CoverLetter: 183 -
-
Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment
1930PDF: 1099HTML: 1893Lung computed tomography CT scan image: 201 -
DETECTION OF OCCULT GLOMERULAR DYSFUNCTION IN GLUCOSE SIX PHOSPHATE DEHYDROGENASE DEFICIENCY ANEMIA
3737PDF: 1248HTML: 1720Untitled: 164 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1391PDF: 691HTML: 1094Untitled: 182Untitled: 149Untitled: 131Untitled: 154Untitled: 161 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1533PDF: 719HTML: 232 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
945PDF: 574HTML: 2194Cover Letter: 190 -
Sickle cell disease and Bartonella spp. infection
1171PDF: 869HTML: 455 -
ROLE OF CYTOKINES AS MOLECULAR MARKER OF DENGUE SEVERITY
3176PDF: 1152HTML: 395 -
IRON DEFICIENCY ANAEMIA AMONG PRE-SCHOOL CHILDREN WITH SICKLE CELL ANAEMIA: STILL A RARE DIAGNOSIS?
1318PDF: 826HTML: 2923cover leer: 147 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1847HTML: 1452PDF: 1088 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1386PDF: 1308HTML: 100 -
-
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4090PDF: 1242HTML: 1955Table 1: 197







